Let's study together! Can you solve this question? Category: USMLE Step 1 > Physiology > Gastrointestinal A 33‑year‑old man reports 6 months of post‑meal bloating, flatulence, and watery stools that are worse after milkshakes and pizza and improve when he avoids dairy. He has no weight loss, fever, hematochezia, nocturnal symptoms, recent antibiotics, or travel. He owns several exotic pets, smokes 1 pack per day (10 pack‑years), and has an opioid use disorder for which he receives supervised buprenorphine‑naloxone. He drinks 1 alcoholic beverage daily. Past history includes tricuspid regurgitation after childhood endocarditis, secondary hyperparathyroidism that resolved, and tardive dyskinesia after prior antipsychotic use. He has seasonal allergies with nasal congestion. Family history is notable for a sister with irritable bowel syndrome. Medications: buprenorphine‑naloxone, calcium/vitamin D, and as‑needed loperamide. Vital signs: temperature 36.8°C, pulse 96/min, respiratory rate 14/min, blood pressure 133/86 mm Hg, oxygen saturation 100% on room air. Physical exam shows mild abdominal distension without tenderness or organomegaly; the remainder is normal. Basic metabolic panel, CBC, thyroid‑stimulating hormone, tissue transglutaminase IgA with total IgA, and C‑reactive protein are normal. A trial of lactose‑free diet for 2 weeks partly improved symptoms. Prior or unrelated chart results include: fundoscopy, chest CT, synovial fluid analysis, core needle biopsy of a neck mass (benign), tumor markers, 24‑hour Holter monitor, urinalysis, exercise stress test, PET scan, thyroid ultrasound, endobronchial ultrasound, CT spine, next‑generation sequencing of a prior lesion, colonoscopy 3 years ago (normal), CT head, hormone levels, in situ hybridization on a prior biopsy, inflammatory markers, and carotid ultrasound—none were abnormal when performed for earlier issues. What is the best next diagnostic test to confirm the suspected diagnosis? **Start empiric long‑term rifaximin daily without testing because small intestinal bacterial overgrowth is the most likely cause of dairy‑related symptoms.** **Perform a hydrogen breath test after a 25–50 g lactose load and diagnose lactose malabsorption if breath hydrogen rises by at least 20 parts per million over baseline.** **Schedule colonoscopy with random biopsies to evaluate for inflammatory bowel disease as the first‑line test for post‑dairy bloating and watery stools despite normal basic labs today.** **Order fecal calprotectin to confirm microscopic colitis before considering any dietary lactose restriction or formal breath testing.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #EndlessMedicalcom #EndlessMedicalAcademy #MultipleChoiceQuestions #Gastrointestinal #Medical #MCQ #Physiology #MedicalEducation #USMLEStep1 #EndlessMedical Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. Diagnosis of Lactose Intolerance - National Institute of Diabetes and Digestive and Kidney Diseases (NIH) - (2024) - by National Institute o... Confidence: 100% Educational value: Provides diagnostic approaches and practical guidance for managing lactose intolerance. niddk.nih.gov/health-informa… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Get better every day and solve this! Category: USMLE Step 1 > Human Anatomy > Cardiac Anatomy A 27-year-old man who runs hilly 10K routes presents for exertional presyncope with rare, abrupt palpitations that occur only during uphill surges and resolve within 1–2 minutes of rest. He denies syncope at rest, stimulant use, or family history of sudden death. He follows a structured training plan, times intervals by heart‑rate zones, and avoids caffeine on workout days. He is celibate, stopped alcohol 10 years ago, and does not smoke. Review of systems notes heat sensitivity from remote optic neuritis; intermittent spring pollen rhinorrhea; and occasional nocturnal calf cramps after hill repeats. Childhood tympanostomy tubes were placed; he uses arch supports for mild pes planus. Past conditions include schizophrenia, Graves’ disease treated to euthyroidism, and relapsing–remitting multiple sclerosis without recent relapse. Remote appendectomy and lactose intolerance are recorded. Family history is negative for hypertrophic or arrhythmic cardiomyopathy; a cousin has mild asthma and an aunt has systemic lupus erythematosus. Medications: propranolol 20 mg three times daily, methimazole 10 mg twice daily, risperidone 2 mg nightly, glatiramer acetate 40 mg subcutaneously three times weekly (last dose three days ago), vitamin D3 2000 IU daily, magnesium oxide 400 mg nightly for cramps, melatonin 3 mg as needed, topical tretinoin cream for acne, loratadine 10 mg as needed, and fluticasone nasal spray 1–2 sprays per nostril as needed. Allergies include latex (contact dermatitis) and penicillin (anaphylaxis). Vitals at rest: pulse 84/min with regular sinus rhythm, respirations 14/min, oxygen saturation 98% on room air, and manual blood pressure 118/68 mm Hg (automated 116/66 mm Hg). Cardiac examination: normal S1/S2, no fixed split, no murmurs or clicks, no rub, and no jugular venous distention at 45°. Peripheral pulses are symmetric without bruits; there is no chest wall tenderness. Skin shows mild facial acne and a healed ear‑piercing scar; running‑related heel calluses are present. Neurologic screening confirms a stable left afferent pupillary defect with otherwise normal exam. Diagnostics over the last 6 months centered on exertional events: a 30‑day ambulatory monitor captured three uphill‑interval episodes with 8–12 beats of monomorphic nonsustained ventricular tachycardia at 180–200/min, one with presyncope; a treadmill stress echocardiogram stopped at Bruce stage III for near‑syncope with nondiagnostic images due to motion; standard resting 12‑lead ECG is normal (PR/QRS/QTc within reference limits); transthoracic echocardiography shows normal chambers and valves without hypertrophic or dilated phenotype; agitated saline via right arm shows no shunt; stress cardiac MRI with quantitative perfusion mapping was nondiagnostic due to respiratory motion; high‑sensitivity troponin after two runs is within reference; coronary calcium score is 0. A chest radiograph at a prior urgent care visit was unremarkable; fasting lipids are optimal for age and hemoglobin A1c is 4.9%. Thyroid function is currently euthyroid on methimazole. A next‑generation sequencing arrhythmia panel reported one RYR2 variant of uncertain significance without a definable syndrome. He asks what anatomic substrate could explain exertional symptoms in a trained adult when conventional functional tests and resting echocardiography have not localized a cause. In this complicated context—young adult with exertional presyncope, brief NSVT during intense uphill effort, nondiagnostic stress imaging, and a structurally normal resting echo—which single next diagnostic test most directly adjudicates a proximal coronary origin–course variant with dynamic compression potential and is most likely to alter management? **Electrophysiology study with isoproterenol‑augmented programmed ventricular stimulation and substrate mapping to uncover adrenergically facilitated VT, planning anomaly‑protocol coronary CTA only if EP testing is nondiagnostic given active debates on noninvasive sensitivity for dynamic compression in adults.** **Invasive coronary angiography as the primary study with pharmacologic provocation and intravascular ultrasound plus resting and adenosine FFR to evaluate for dynamic ostial compression and translesional pressure loss, reserving noninvasive anatomic delineation for surgical planning only if invasive hemodynamics suggest an anomalous course.** **Stress cardiac MRI at 3T using dual‑sequence, quantitative perfusion with myocardial blood‑flow reserve thresholds and 4D‑flow mapping to phenotype ischemia and scar while deferring explicit anatomic delineation of ostial origin and intramural length unless perfusion defects or scar localization later mandate targeted anatomy imaging.** **Coronary CT angiography performed with a dedicated coronary anomaly protocol using prospective ECG‑gating, sublingual nitroglycerin for vasodilation unless contraindicated, beta‑blocker for heart‑rate control if needed, and thin‑slice multiplanar/3D reconstructions to define ostial origin, interarterial or intramural course, and slitlike orifice morphology that functional tests may not reveal.** 🎬 Watch the video explanation: youtube.com/watch?v=OVaCWJcn… The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #MultipleChoiceQuestions #MedicalEducation #EndlessMedical #EndlessMedicalcom #USMLEStep1 #HumanAnatomy #EndlessMedicalAcademy #CardiacAnatomy #MCQ #Medical Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. Anomalous Aortic Origin of the Coronary Artery - American College of Cardiology - (2025) - by American College of ... Confidence: 100% Educational value: Concise overview of imaging approach and management for suspected AAOCA in athletes. acc.org/Latest-in-Cardiology… 2. Anomalous Aortic Origin of a Coronary Artery in Adults - Annals of Thoracic Surgery - (2021) - by Angelini P.; Uribe C... Confidence: 100% Educational value: Helps learners connect anatomy to symptoms and choose imaging that alters management. pubmed.ncbi.nlm.nih.gov/3327… 3. ACC/AHA issue new guideline on managing congenital heart disease in adults - American College of Cardiology/American Heart Association - (2025) - by American College of ... Confidence: 100% Educational value: Authoritative recommendations for diagnosing and managing AAOCA in adult athletes. newsroom.heart.org/news/acca… 4. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain - American College of Cardiology/American Heart Association - (2021) - by ACC/AHA Joint Commit... Confidence: 100% Educational value: Clarifies when CCTA is the next test in exertional symptoms with normal echo and equivocal stress imaging. pubmed.ncbi.nlm.nih.gov/3495… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Today we will learn about... Category: USMLE Step 1 > Pathology > Immunopathology A 30-year-old man presents to the medical ICU with abrupt hemoptysis, dark cola-colored urine, pleuritic chest discomfort, and rapidly progressive fatigue over 36 hours. He reports a recent upper respiratory irritation at work as a respiratory therapist and routine exposure to disinfectant solvents during equipment processing. He denies fever, weight loss, or night sweats. Family history includes rheumatoid arthritis in his mother and autoimmune thyroid disease in an uncle. He does not take anticoagulants. He wears rigid gas-permeable lenses for keratoconus and returned from a short tropical trip 2 weeks ago without lingering illness. On arrival he is pale, diaphoretic, and tachypneic with blood-tinged sputum. Vital signs: pulse 130/min, blood pressure 86/56 mm Hg, respiratory rate 24/min, temperature 36.1°C, oxygen saturation 98% on nonrebreather at 15 L/min. Examination shows bibasilar fine crackles, conjunctival pallor, mild bilateral ankle edema, and no rash, livedo, or joint swelling. A healed arthroscopy scar on the right knee is noted without tenderness. Initial laboratory studies reveal hemoglobin 6.8 g/dL, leukocytes 14,200/µL with neutrophil predominance, platelets 278,000/µL, sodium 138 mEq/L, potassium 4.9 mEq/L, bicarbonate 18 mEq/L, BUN 76 mg/dL, creatinine 5.2 mg/dL (baseline 0.9 mg/dL three months prior), ESR 72 mm/h, and CRP 15 mg/dL. Urinalysis shows 3 blood, 2 protein, dysmorphic erythrocytes, and numerous RBC casts. Portable chest radiography demonstrates new diffuse bilateral perihilar opacities without cardiomegaly. ECG shows sinus tachycardia. Two sets of blood cultures show no growth at 8 hours. Point-of-care troponin is normal. Bronchoscopy with sequential bronchoalveolar lavage returns progressively bloodier aliquots without endobronchial lesions. Rapid respiratory viral PCR (including SARS-CoV-2) is negative. Autoimmune serologies are sent: PR3-ANCA and MPO-ANCA with rapid ELISA (turnaround 24–48 hours) and anti–glomerular basement membrane (anti-GBM) ELISA (turnaround up to 72 hours). Given persistent hemoptysis with rising creatinine and active urinary sediment, percutaneous renal biopsy is performed after transfusing packed RBCs and administering desmopressin. Kidney biopsy (urgent read): light microscopy shows cellular crescents in approximately 85% of glomeruli with fibrinoid necrosis and minimal interstitial fibrosis. Immunofluorescence demonstrates strong linear IgG along glomerular basement membranes with C3 co-deposition; no granular immune complex pattern. Electron microscopy shows absence of electron-dense immune complex deposits and widespread GBM breaks at necrotic segments. Repeat basic metabolic panel 6 hours later confirms worsening kidney function (creatinine 5.6 mg/dL) with persistent metabolic acidosis and stable platelets. Hemodynamics improve modestly after balanced crystalloids and 1 unit PRBC. Selected prior data available in the chart include spirometry one year ago with a mild restrictive pattern and a Holter monitor ten months ago showing sinus tachycardia without ectopy. No prior autoantibody testing is on file. Current medications and substances: buprenorphine–naloxone 16 mg/4 mg sublingual daily (last dose yesterday), omeprazole 20 mg daily, ibuprofen 800 mg three times daily as needed for knee pain (frequent over the past two weeks), melatonin 5 mg nightly, a multivitamin, and occasional pseudoephedrine for congestion; no known drug allergies. The ICU night team debates whether to wait for confirmatory serologies before initiating extracorporeal therapy. Based on the data above, which management decision represents the key clinical pitfall to avoid at this moment? **Deferring therapeutic plasma exchange until anti-GBM ELISA returns, rather than initiating immediately with daily one–plasma-volume exchanges (approximately 60 mL/kg albumin replacement), plus IV methylprednisolone 500–1000 mg/day for 3 days and oral cyclophosphamide 2 mg/kg/day given biopsy-proven linear IgG crescents with diffuse alveolar hemorrhage.** **Initiating daily plasma exchange and high-dose steroids immediately but substituting rituximab 375 mg/m² weekly for four doses as first-line cytotoxic therapy to preserve fertility, planning to add cyclophosphamide only if anti-GBM ELISA and ANCA both become positive.** **Starting therapeutic plasma exchange now but performing exchanges every other day at 1.5 plasma volumes, combined with IV pulse cyclophosphamide and low-dose steroids, while awaiting anti-GBM ELISA to decide whether to intensify to daily exchanges later in the week.** **Heparinizing for presumed pulmonary embolism due to tachycardia and hypoxemia risk while holding immunosuppression pending final cultures and broad viral testing, then reconsidering kidney-directed therapy only after serologies are definitive.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #EndlessMedicalAcademy #EndlessMedical #USMLEStep1 #MCQ #EndlessMedicalcom #Medical #MedicalEducation #Pathology #MultipleChoiceQuestions #Immunopathology Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases (includes anti-GBM GN recommendations) - KDIGO - (2021) - by Rovin BH, Adler SG, ... Confidence: 100% Educational value: Clarifies diagnostic criteria and time-critical management to avoid delay-related harm. pubmed.ncbi.nlm.nih.gov/3455… 2. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: The Ninth Special Issue (ASFA) - ASFA - (2023) - by Connelly-Smith L, Al... Confidence: 100% Educational value: Provides indications, urgency, and operational guidance for therapeutic plasma exchange. pubmed.ncbi.nlm.nih.gov/3701… 3. Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease. - Journal of the American Society of Nephrology - (2022) - by Kardolus R, Confidence: 100% Educational value: Helps learners link biopsy and presentation severity to outcomes and urgency of intervention. pubmed.ncbi.nlm.nih.gov/3644… 4. Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage. - Journal of Clinical Apheresis - (2023) - by Katsumata Y, Confidence: 100% Educational value: Offers real-world evidence on PLEX utility and decision-making in advanced disease. pubmed.ncbi.nlm.nih.gov/3735… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Let's study together! Can you solve this question? Category: Nephrology: Kidney Disease Diagnosis and Management > Interstitial Nephritis A 67-year-old woman with psoriasis comes to the emergency department with 2 days of feeling unwell, an itchy red rash on the chest, mild pain in both flanks, and passing less urine. Ten days ago she started omeprazole 20 mg daily for heartburn. For several months she has taken naproxen 500 mg twice daily for joint pain and uses topical calcipotriene for her skin. Vital signs: temperature 37.3 °C, pulse 82/min, respiratory rate 19/min, blood pressure 144/97 mm Hg, oxygen saturation 96% on room air. Initial tests: creatinine 2.1 mg/dL (was 0.9 mg/dL two weeks ago), BUN 41 mg/dL; basic electrolytes are within usual limits. Urinalysis shows 2 protein, positive leukocyte esterase, white blood cell casts, 10–15 white cells and 5–7 red cells per high-power field; urine culture shows no growth at 48 hours. Kidney ultrasound shows normal‑sized kidneys without blockage. The ED doctor plans to admit the patient and, while waiting for nephrology to see her, intends to continue all home medicines and start intravenous piperacillin–tazobactam for a possible infection. In the setting of suspected drug‑related kidney inflammation, which action is the most common management error that could delay kidney recovery in this patient? **Beginning high‑dose steroid treatment right away before the kidney specialist reviews the case and before all possible culprit drugs are stopped** **Waiting to call the kidney specialist until a kidney biopsy can be scheduled later in the week rather than requesting consultation during admission** **Stopping naproxen but also starting broad‑spectrum intravenous antibiotics until infection is ruled out even though the urine culture is currently negative and there are no clear infection signs** **Continuing the pain medicine naproxen instead of stopping all likely offending drugs immediately when drug‑induced kidney inflammation is suspected** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #MultipleChoiceQuestions #EndlessMedical #MCQ #Medical #NephrologyKidneyDiseaseDiagnosisandManagement #InterstitialNephritis #EndlessMedicalAcademy #MedicalEducation #EndlessMedicalcom Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. Allergic and Drug‑Induced Interstitial Nephritis (StatPearls, NCBI Bookshelf) - (2023) - by Finnigan NA; Rout P;... Confidence: 100% Educational value: Provides an up-to-date, structured overview that helps learners recognize AIN presentations, differentiate from other AKI etiologies, and apply stepwise diagnostic and treatment strategies. ncbi.nlm.nih.gov/books/NBK48… 2. Diagnosis and Management of Acute Interstitial Nephritis (American Family Physician, 2003) - (2003) - by Praga M; González E Confidence: 100% Educational value: Offers detailed clinical pearls and classic teaching points on AIN pathophysiology, diagnostic clues, and management considerations that complement newer summaries. aafp.org/pubs/afp/issues/200… 3. KDIGO Clinical Practice Guideline for Acute Kidney Injury - (2012) - by KDIGO Work Group Confidence: 100% Educational value: Provides the foundational AKI staging and management framework that helps learners integrate AIN within broader AKI care pathways and guideline-based practices. kdigo.org/guidelines/acute-k… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Learn about... Category: USMLE Step 1 > Physiology > Endocrine A 20-year-old male with known primary adrenal insufficiency (autoimmune, diagnosed at 17) is brought to the emergency department from a supervised group residence for vomiting and near‑syncope. Outpatient medications: hydrocortisone 10 mg each morning and 5 mg early afternoon; fludrocortisone 0.1 mg daily; cholecalciferol. He missed his morning hydrocortisone dose because of nausea. He does not drink alcohol and denies recreational drugs. Allergies: shellfish (hives). Vitals: temperature 37.2°C, pulse 125/min, respiratory rate 18/min, blood pressure 111/71 mmHg, SpO2 92% on room air improving to 97% on 4 L/min oxygen. He appears ill and confused with cool extremities and delayed capillary refill. Laboratory testing: sodium 121 mEq/L, potassium 6.2 mEq/L, chloride 92 mEq/L, bicarbonate 15 mEq/L, glucose 54 mg/dL, BUN 28 mg/dL, creatinine 1.4 mg/dL. ECG shows sinus tachycardia with peaked T waves; troponin normal. A trainee suggests drawing morning cortisol and ACTH and waiting for results before giving steroids. You supervise care in the resuscitation bay. Considering current endocrine guidance and medicolegal risk in a time‑critical endocrine emergency, which action best avoids a common legal pitfall and aligns with standards of care? **Administer dexamethasone 4 mg IV once to preserve assay interpretation and defer stress‑dose hydrocortisone until lab results return later today** **Begin vasopressors first and wait to give glucocorticoids until after central access and ICU admission to limit potential fluid overload and masking effects before steroids** **Give hydrocortisone 100 mg IV immediately, then 50–100 mg IV every 6–8 hours with isotonic fluids; do not delay empiric treatment for cortisol or ACTH results** **Complete ACTH stimulation testing now and start hydrocortisone only after biochemical confirmation to avoid obscuring the diagnosis in future encounters** 🎬 Watch the video explanation: youtube.com/watch?v=f09aHIt_… The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #USMLEStep1 #EndlessMedical #EndlessMedicalcom #EndlessMedicalAcademy #Endocrine #Medical #Physiology #MedicalEducation #MultipleChoiceQuestions #MCQ Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. Adrenal insufficiency: identification and management (NG243) — emergency management of adrenal crisis - NICE - (2024) - by National Institute f... Confidence: 100% Educational value: Clarifies emergency dosing, escalation, and monitoring steps for adrenal crisis. nice.org.uk/guidance/ng243/c… 2. Diagnosis and Treatment of Primary Adrenal Insufficiency - Endocrine Society - (2016) - by Bornstein SR, Alloli... Confidence: 100% Educational value: Provides baseline therapy regimens, stress dosing, and monitoring principles. endocrine.org/clinical-pract… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

I challenge you today to solve this question! Category: USMLE Step 1 > Human Anatomy > Vascular Anatomy A 32-year-old man is brought to the emergency department after suddenly collapsing while watching television. He has a history of heart failure with preserved ejection fraction, multiple sclerosis treated with glatiramer acetate, esophageal cancer diagnosed 3 years ago and now in remission after chemoradiation, and cerebral palsy. He drinks 3–4 alcoholic beverages weekly. He is allergic to amoxicillin (swelling). Home medications include glatiramer acetate injections and loratadine 10 mg as needed for seasonal allergies. He reports a brief mild headache last week that resolved and no recent fever, chest pain, or trauma. On arrival he is very sleepy and hard to arouse with minimal breathing effort. Vital signs: temperature 36.5°C, pulse 44/min, blood pressure 102/17 mm Hg, oxygen saturation 94% on room air, and observed respiratory rate 1/min increasing to 8/min after airway positioning. Pupils are small but reactive. Vertical eye movements and blinking to command are preserved. There is no facial droop. Limbs do not move to pain, and plantar responses are flexor. A small bruise is seen over the right knee without deformity. Initial ED actions: stroke team activated; noncontrast head CT done within minutes shows no bleeding. A vessel scan (CT angiography) of head and neck shows a clot blocking the basilar artery. A perfusion scan shows reduced blood flow to the back of the brain. Point-of-care glucose is 98 mg/dL. A rapid EEG shows reactivity without seizures. Basic labs are within normal limits, including troponin I 0.01 ng/mL and electrolytes. Liver enzymes are normal. After 1 liter of normal saline, blood pressure increases to 108/64 mm Hg; oxygen saturation remains 94% with airway support. He remains awake enough to look up and down but cannot move arms or legs. Which statement best describes the likely natural course of this vascular condition if restoring blood flow cannot be achieved quickly? **In many young adults, basilar artery clots partly reopen on their own, and most survivors have only mild to moderate disability without restoring blood flow or using catheter procedures.** **A tear in a single vertebral artery usually causes neck pain and dizziness and often heals with medicines and rest, with major long‑term disability being uncommon.** **Blocking the anterior cerebral artery mainly causes leg weakness and behavior changes and rarely threatens breathing or alertness, so death is unusual even without restoring blood flow.** **Without early restoration of blood flow, a clot in the basilar artery commonly leads to coma and death or severe, permanent disability; early clot‑dissolving medicine or catheter clot removal improves outcomes.** 🎬 Watch the video explanation: youtube.com/watch?v=iJFUgs2Z… The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #USMLEStep1 #Medical #EndlessMedicalAcademy #HumanAnatomy #MultipleChoiceQuestions #MedicalEducation #VascularAnatomy #EndlessMedicalcom #EndlessMedical #MCQ Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. European Stroke Organisation and European Society for Minimally Invasive Neurological Therapy guideline on acute management of basilar artery occlusion - European Stroke Organisation; European Society for Minimally Invasive Neurological Therapy - (2024) - by Strbian D.; Tsivgoul... Confidence: 100% Educational value: Summarizes natural history, clinical presentation, and urgency of revascularization in BAO. pmc.ncbi.nlm.nih.gov/article… 2. Focused update to guidelines for endovascular therapy for emergent large vessel occlusion: basilar artery occlusion patients (SNIS Standards and Guidelines Committee) - Society of NeuroInterventional Surgery (SNIS) - (2024) - by Heit JJ.; Chaudhary ... Confidence: 100% Educational value: Clarifies indications and urgency for endovascular therapy, reinforcing the prognostic implications of delayed reperfusion. pubmed.ncbi.nlm.nih.gov/3867… 3. Endovascular Thrombectomy in Basilar‑Artery Occlusion Stroke (ATTENTION) - New England Journal of Medicine - (2022) - by Tao C.; Nogueira R. ... Confidence: 100% Educational value: Demonstrates outcome differences that illustrate the high morbidity/mortality of untreated BAO. pubmed.ncbi.nlm.nih.gov/3623… 4. Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar‑Artery Occlusion (BAOCHE) - New England Journal of Medicine - (2022) - by Jovin T. G.; Li C.; ... Confidence: 100% Educational value: Reinforces natural history and time‑sensitive benefit of recanalization in BAO. pubmed.ncbi.nlm.nih.gov/3623… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Get better every day and solve this! Category: Clinical Pathology > Therapeutic plasma exchange > Metabolic Disorders and TPE A 59-year-old G3P1 woman at 24 weeks of gestation after donor-egg IVF is transported to a tertiary emergency department for abrupt severe epigastric pain radiating to the back with repeated vomiting over 6 hours. She reports that earlier the same day a walk-in clinic phlebotomist noted that her blood sample looked unusually turbid and milky. She works as a site scheduler for a construction firm, lives with her spouse, denies alcohol or illicit drugs, and has no known drug allergies. Pregnancy has been followed by a high-risk maternal–fetal medicine service because of advanced maternal age, donor-egg conception, and intermittent gestational hypertension. Outpatient medications include prenatal vitamins with iron and folate, low-dose aspirin 81 mg nightly, cholecalciferol 1000 IU daily, doxylamine–pyridoxine at bedtime for nausea, and labetalol 100 mg orally twice daily started one week ago for elevated home blood pressures. Records from the first trimester list a fasting lipid panel with triglycerides 520 mg/dL and LDL-C 110 mg/dL and baseline obstetric labs otherwise unremarkable; an echocardiogram 6 months before conception showed normal LVEF 60% without valvular disease. Routine screening Pap smear last year was negative and a prior vitamin D level had been low (19 ng/mL) but was corrected. On arrival she appears ill and diaphoretic. Initial vital signs repeatedly confirm hypotension: pulse 94 bpm, temperature 36.0°C, respiratory rate 19 breaths/min, blood pressure 43/13 mm Hg (MAP 23–25), and oxygen saturation 94% on 2 L/min nasal cannula. Abdomen is distended with epigastric guarding and hypoactive bowel sounds. Heart has regular rhythm without murmurs; lungs are clear without crackles. Skin shows no xanthomas. Neurologic exam reveals an oriented but intermittently lethargic patient. Uterus is nontender. Continuous external fetal heart monitoring shows baseline 150 bpm with minimal variability and intermittent variable decelerations. Physical exam also notes a few varicose veins at the ankles and mild crepitus of the knees. Initial emergency department results during the first hour include hematocrit 30%, WBC 15,800/µL, platelets 214,000/µL, sodium 134 mEq/L, potassium 4.8 mEq/L, chloride 98 mEq/L, bicarbonate 14 mEq/L, creatinine 1.2 mg/dL, glucose 236 mg/dL, total calcium 7.4 mg/dL (albumin 2.2 g/dL), AST 98 U/L, ALT 72 U/L, total bilirubin 1.1 mg/dL, lactate 5.2 mmol/L, triglycerides 3,500 mg/dL, amylase 288 U/L, and lipase 1,240 U/L. Venous blood gas: pH 7.23, pCO2 32 mm Hg, HCO3− 13 mEq/L. Urinalysis reveals 1 ketones. Point-of-care abdominal ultrasound demonstrates an edematous, noncompressible pancreas with peripancreatic fluid and a gallbladder without stones or wall thickening. A formal obstetric ultrasound confirms a single live fetus with estimated weight appropriate for gestational age and no abruption. A right-upper-quadrant ultrasound from early pregnancy showed no gallstones. She weighs 72 kg. Central venous access is obtained; 3.5 L of warmed lactated Ringer’s are infused, and norepinephrine is titrated to 0.18 µg/kg/min. An intravenous insulin infusion is started at 0.1 units/kg/hour with hourly dextrose adjustments targeting glucose 140–180 mg/dL; triglycerides decrease by less than 10% in the first 2 hours. Ionized calcium is low, and intravenous calcium gluconate is begun. Broad-spectrum antibiotics are withheld pending cultures in the absence of fever, chorioamnionitis, or cholangitis. Contrast-enhanced CT is deferred because of persistent hypotension and pregnancy. The hospital apheresis service confirms it can mobilize to the ICU within 2 hours. In the ICU she has persistent hypotension requiring vasopressors, ongoing severe pain, metabolic acidosis with elevated lactate, and concerning fetal tracings. The team asks which action should be prioritized now to stabilize both mother and fetus in severe hypertriglyceridemia-associated pancreatitis with organ dysfunction despite aggressive fluids and insulin. Which intervention should be prioritized now? **Escalate medical therapy only by increasing insulin to 0.2 units/kg/hour with dextrose titration and defer any apheresis for 24–48 hours, maintaining crystalloid resuscitation, vasopressors, and ICU monitoring.** **Start a continuous unfractionated heparin infusion at 12 units/kg/hour to release lipoprotein lipase, add gemfibrozil 600 mg orally twice daily now, and plan to recheck triglycerides the next day before considering any extracorporeal therapy.** **Initiate emergent therapeutic plasma exchange within 6 hours, exchanging 1.5 calculated plasma volumes (≈4.9 L for a 72‑kg woman with hematocrit 0.30) with 5% albumin replacement and regional citrate anticoagulation, while continuing intravenous insulin 0.1 units/kg/hour, aggressive lactated Ringer’s, vasopressors, and continuous fetal monitoring in the ICU.** **Proceed with double‑filtration plasmapheresis exchanging 1.0 plasma volume (≈3.3 L) using fresh frozen plasma replacement and systemic unfractionated heparin anticoagulation, and hold the insulin infusion during the session to avoid hypoglycemia while continuing ICU supportive care.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #Therapeuticplasmaexchange #EndlessMedicalcom #EndlessMedical #MCQ #MedicalEducation #EndlessMedicalAcademy #ClinicalPathology #MetabolicDisordersandTPE #Medical #MultipleChoiceQuestions Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – The Ninth Special Issue (ASFA 2023) - ASFA - (2023) - by Connelly–Smith L, Al... Confidence: 100% Educational value: Clarifies when to escalate from insulin to apheresis and expected benefits/targets. pubmed.ncbi.nlm.nih.gov/3701… 2. Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia‑associated acute pancreatitis - Annals of Intensive Care - (2024) - by Wang L; Zhou J; Lv C Confidence: 100% Educational value: Provides outcome data to contextualize TPE timing and expected clinical impact. annalsofintensivecare.spring… 3. The role of apheresis and insulin therapy in hypertriglyceridemic acute pancreatitis—A concise review - BMC Gastroenterology - (2023) - by Gubensek J Confidence: 100% Educational value: Helps learners weigh insulin infusion vs TPE and understand triglyceride‑lowering kinetics, including in pregnancy. bmcgastroenterol.biomedcentr… 4. Initial management of acute pancreatitis (AGA Clinical Guidance) - AGA - (2018) - by Crockett SD, Wani S,... Confidence: 100% Educational value: Frames supportive care priorities while definitive HTG therapy proceeds. gastro.org/clinical-guidance… 5. Pancreatitis | MedlinePlus - MedlinePlus - (2025) - by National Library of ... Confidence: 100% Educational value: Introductory resource to complement technical guidelines and studies. medlineplus.gov/pancreatitis… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Today we will learn about... Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management A 49-year-old woman presents to clinic 3 days after hospital discharge with a new diagnosis of pauci-immune crescentic glomerulonephritis consistent with ANCA-associated vasculitis (biopsy performed during admission; immunofluorescence was pauci-immune). She is starting induction therapy today. She reports nonproductive cough for a week without fever, and 2 watery stools yesterday after eating at work. She works in food service and recently moved into a job in education support at a local school; she reports frequent exposure to cleaning chemicals at work. She has a past history of renal cell carcinoma treated with partial nephrectomy 5 years ago and mixed connective tissue disease with Raynaud phenomenon. Allergies include shellfish (urticaria) and amoxicillin (lip and facial swelling). She denies dyspnea, chest pain, oral ulcers, or rash. Vital signs today: pulse 132/min (restless and anxious), respiratory rate 28/min, blood pressure 102/64 mmHg (ED reading was 82/21 mmHg before fluids), temperature 37.4°C, oxygen saturation 97% on room air. Physical examination shows clear lungs, no oral thrush, no skin rash, and no focal neurologic deficits. Baseline labs today: creatinine 1.1 mg/dL (eGFR ~62 mL/min/1.73 m²), bicarbonate 22 mEq/L, sodium 135 mEq/L, chloride 100 mEq/L, white blood cells 8,900/µL with normal differential, hemoglobin 11.3 g/dL, platelets 310,000/µL, AST/ALT normal, urinalysis with 2 blood and 1 protein. Stool culture from two days ago (submitted for diarrhea at discharge) is negative for Salmonella and Shigella; thyroid ultrasound (done for a palpable fullness at a previous visit) shows a benign colloid nodule. She started prednisone 60 mg daily yesterday and is scheduled for rituximab 1,000 mg IV on days 1 and 15 as an outpatient. She is not taking any antimicrobial prophylaxis and is otherwise on omeprazole 20 mg daily and amlodipine 5 mg daily. In simple terms and as a single next action today, what should be started to reduce her near-term risk of a serious treatment-related infection while she undergoes induction therapy? **Begin Pneumocystis prophylaxis now with trimethoprim–sulfamethoxazole, for example one double‑strength (160/800 mg) tablet by mouth three times weekly (or one single‑strength tablet daily) while she receives high‑dose prednisone and rituximab.** **Add valacyclovir 500 mg by mouth once daily to prevent shingles during rituximab and hold Pneumocystis prophylaxis until creatinine rises.** **Start atovaquone 1,500 mg by mouth once daily with food as Pneumocystis prophylaxis because it avoids sulfa, even though she has no sulfonamide allergy.** **No prophylaxis is needed yet because her creatinine and white blood cell count are normal and she has no respiratory symptoms.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #GlomerulonephritisCausesDiagnosisandManagement #Medical #PauciImmuneGlomerulonephritisGN #MCQ #EndlessMedicalcom #NephrologyKidneyDiseaseDiagnosisandManagement #EndlessMedicalAcademy #AcuteKidneyInjuryManagement #EndlessMedical #MedicalEducation #MultipleChoiceQuestions Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis - KDIGO - (2024) - by KDIGO ANCA Vasculiti... Confidence: 100% Educational value: Clarifies induction regimens and supportive care, including indications and agents for infection prophylaxis (e.g., TMP-SMX). pubmed.ncbi.nlm.nih.gov/3838… 2. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis - American College of Rheumatology/Vasculitis Foundation - (2021) - by Chung, S. A., Confidence: 100% Educational value: Offers practical infection prevention guidance for immunosuppressed AAV patients. pubmed.ncbi.nlm.nih.gov/3423… 3. Tables: Preferred and Alternative Therapies for HIV-Associated Opportunistic Infections (dosing tables include TMP–SMX prophylaxis schedules used in clinical practice) - U.S. Department of Health and Human Services/NIH - (2024) - by U.S. Department of H... Confidence: 100% Educational value: Serves as a dosing reference for selecting and adjusting TMP-SMX prophylaxis regimens. clinicalinfo.hiv-stage.od.ni… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Today we will learn about... Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management A 40-year-old manufacturing worker with central diabetes insipidus and a remote varicocele presents with 24 hours of severe occipital headache, blurry vision, and tea‑colored urine. He denies recent angiography, vascular surgery, anticoagulant use, cocaine, or NSAIDs. Over the last month he recorded home blood pressures of 165–180/100–110 mmHg; losartan 50 mg daily was started 3 weeks ago. He drinks 1–2 alcoholic beverages per week, does not smoke, and has no known drug allergies. There is no family history of kidney disease; his father has hypertension. On arrival: temperature 38.1 C, heart rate 148 beats/min, respiratory rate 20 breaths/min, oxygen saturation 95% on 2 L/min by nasal cannula, and blood pressure 220/140 mmHg. He is agitated. Funduscopic examination reveals flame hemorrhages, cotton‑wool spots, and blurred disc margins. Lungs are clear. Cardiac exam shows tachycardia without murmurs. Skin is warm without livedo, ulcerations, or blue toes. Neurologic exam shows intact cranial nerves and full strength without foot drop or sensory level. Nasal mucosa is normal without crusting; there is no sinus tenderness. Abdomen is soft without bruits. Laboratory results: hemoglobin 11.0 g/dL, leukocytes 10.2 ×10^9/L, platelets 280 ×10^9/L, LDH mildly elevated, haptoglobin normal, peripheral smear without schistocytes. Sodium 141 mEq/L, potassium 4.9 mEq/L, bicarbonate 20 mEq/L, BUN 38 mg/dL, creatinine 3.2 mg/dL (prior 1.0 mg/dL 6 months ago). Estimated GFR by 2021 CKD‑EPI for a 40‑year‑old man with creatinine 3.2 mg/dL is approximately 24 mL/min/1.73 m^2. Urinalysis: 2 protein, 3 blood with dysmorphic RBCs and several RBC casts. Complements normal; ANA negative; MPO‑ANCA and PR3‑ANCA pending. Noncontrast head CT shows no hemorrhage. Bedside renal ultrasound: normal‑sized kidneys without hydronephrosis. He has not undergone any recent vascular instrumentation. Prior data: PET‑CT 8 months ago for weight loss showed no hypermetabolic lesions; cystoscopy 3 years ago for microscopic hematuria was normal; karyotype 46,XY. Based on the discriminating historical and examination features together with the laboratory pattern, which diagnosis best fits this presentation? **Pauci‑immune crescentic glomerulonephritis due to ANCA‑associated vasculitis with malignant‑phase hypertension unmasking active nephritic sediment.** **IgA nephropathy with a synpharyngitic flare explaining dysmorphic hematuria in the setting of severe hypertension.** **Cholesterol atheroembolic kidney disease after recent angiography, presenting with livedo reticularis, eosinophilia, and blue toe syndrome.** **Malignant hypertension with acute hypertensive nephrosclerosis as the sole cause of hematuria and red blood cell casts without underlying vasculitis.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #EndlessMedical #NephrologyKidneyDiseaseDiagnosisandManagement #MCQ #EndlessMedicalcom #PauciImmuneGlomerulonephritisGN #MultipleChoiceQuestions #GlomerulonephritisCausesDiagnosisandManagement #Medical #EndlessMedicalAcademy #AcuteKidneyInjuryManagement #MedicalEducation Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis - KDIGO - (2024) - by Floege J; Jayne DRW;... Confidence: 100% Educational value: Summarizes indications for ANCA testing, biopsy, and induction therapy in rapidly progressive GN. pubmed.ncbi.nlm.nih.gov/3838… 2. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update - EULAR - (2024) - by Hellmich B; Sanchez-... Confidence: 100% Educational value: Clarifies diagnostic approach and treatment choices (e.g., glucocorticoids, rituximab/cyclophosphamide) in AAV. pubmed.ncbi.nlm.nih.gov/3692… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

This question is for you! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Therapeutic Immunosuppression A 42-year-old woman is brought to the emergency department with sudden hemoptysis, pleuritic chest pain, and oliguria over 24 hours. She has a history of rheumatoid arthritis (on intermittent low‑dose prednisone bursts in the past, currently off), multiple sclerosis (stable), and type 2 diabetes. Dermatology treated actinic keratoses last year. She works in health care. She quit smoking 10 years ago after 30 pack‑years but restarted during the pandemic and currently smokes 1 pack/day; there is a remote history of injection drug use. She reports dust mite allergy with sneezing only. Medications at home include metformin 1 g twice daily, atorvastatin 20 mg nightly, albuterol as needed, and occasional ibuprofen; no hydralazine or antithyroid drugs. Triage: temperature 36.2°C, pulse 83/min, respiratory rate 22/min (initially 9/min recorded while drowsy, improved with stimulation), BP 122/84 mm Hg, SpO2 94% on 3 L/min nasal cannula. Exam shows pallor, bibasilar crackles, trace pedal edema, and no rash. Labs: hemoglobin 9.6 g/dL, platelets 295,000/µL, WBC 11,900/µL; creatinine 2.1 mg/dL (baseline 0.8), BUN 41 mg/dL; eGFR (CKD‑EPI 2021) 29.6 mL/min/1.73 m²; bicarbonate 20 mEq/L. Urinalysis shows 3 blood and 2 protein with many dysmorphic RBCs and RBC casts. Complements are normal. Rapid respiratory viral PCR panel is negative; procalcitonin is low. Chest radiograph reveals bilateral perihilar opacities. Prior evaluations within the last year for musculoskeletal complaints included knee arthroscopy (degenerative changes only). Pulmonary clinic spirometry showed normal FEV1/FVC but reduced DLCO; a thoracoscopy for a prior pleural effusion elsewhere yielded nonspecific inflammation. Ophthalmology fluorescein angiography for blurred vision showed mild diabetic changes without vasculitis. Today’s bronchoscopy for ongoing hemoptysis demonstrates diffuse alveolar hemorrhage without endobronchial lesions; lavage cultures are pending and initial Gram stain shows no organisms. Standard approaches (antibiotic coverage, CT‑pulmonary angiography deferred for renal function, bronchoscopy) have not identified a cause for this pulmonary–renal picture. Which diagnostic approach is most likely to establish the underlying etiology now? **Rely on serologic screening alone by adding ANA, ENA panel, and repeat complements to infer the glomerular pathology without tissue confirmation.** **Expedited native‑kidney biopsy with comprehensive evaluation (light microscopy, immunofluorescence, and electron microscopy) to confirm pauci‑immune necrotizing crescentic GN and direct immunosuppressive therapy.** **Repeat bronchoscopy with transbronchial biopsies after 24–48 hours to obtain additional pulmonary tissue before considering renal tissue diagnosis.** **Order high‑resolution chest CT and await complete infectious studies, postponing invasive testing until cultures finalize.** 🎬 Watch the video explanation: youtube.com/watch?v=3iGOVvQp… The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #NephrologyKidneyDiseaseDiagnosisandManagement #EndlessMedical #TherapeuticImmunosuppression #MedicalEducation #EndlessMedicalcom #Medical #EndlessMedicalAcademy #PauciImmuneGlomerulonephritisGN #MultipleChoiceQuestions #MCQ #GlomerulonephritisCausesDiagnosisandManagement Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis - KDIGO - (2024) - by KDIGO ANCA Vasculiti... Confidence: 100% Educational value: Summarizes when to use ANCA serology and tissue biopsy and outlines differential diagnosis for pulmonary–renal presentations. pubmed.ncbi.nlm.nih.gov/3838… 2. 2025 British Society for Rheumatology management recommendations for ANCA‑associated vasculitis (Executive summary) - British Society for Rheumatology - (2025) - by British Society for ... Confidence: 100% Educational value: Clarifies practical diagnostic steps and decision-making for acute AAV presentations. academic.oup.com/rheumatolog… 3. Plasma Exchange and Glucocorticoids in Severe ANCA‑Associated Vasculitis (PEXIVAS) - New England Journal of Medicine - (2020) - by Walsh M, Merkel PA, ... Confidence: 100% Educational value: Helps learners connect diagnostic confirmation of AAV to evidence-based initial treatment strategies. pubmed.ncbi.nlm.nih.gov/3205… 4. Vasculitis — MedlinePlus Health Topic - U.S. National Library of Medicine - (2024) - by U.S. National Librar... Confidence: 100% Educational value: Provides accessible background on symptoms, tests, and types of vasculitis. medlineplus.gov/vasculitis.h… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Get better every day and solve this! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Therapeutic Immunosuppression A 51-year-old man presents with 2 weeks of exertional dyspnea, sinus congestion with crusting epistaxis, pleuritic chest pain, and cola‑colored urine. He reports night sweats and fatigue without weight gain or edema. Past medical history includes chronic obstructive pulmonary disease (stable), essential hypertension, and hyperlipidemia; remote right knee meniscectomy and childhood varicella are noted. He quit smoking 5 years ago after 30 pack‑years and denies alcohol or cocaine use. He has no recent travel and no occupational silica exposure. Family history is noncontributory. Medications: amlodipine 10 mg each morning, atorvastatin 20 mg nightly, tiotropium 18 mcg inhaled daily, albuterol HFA 2 puffs as needed, buprenorphine–naloxone 8/2 mg sublingual daily, omeprazole 20 mg daily, vitamin D3 1,000 IU daily, multivitamin daily, topical terbinafine cream nightly. He is not taking hydralazine, propylthiouracil, minocycline, or allopurinol. Allergies: sesame (rash) and aspirin (angioedema). On exam: temperature 37.6°C, pulse 63/min, respiratory rate 12/min, BP 201/113 mm Hg, SpO2 98% on room air. There is nasal crusting with septal tenderness, fine bibasilar crackles, and trace pedal edema. No wheeze is heard. No palpable purpura is seen. Skin shows scattered seborrheic keratoses and mild onychomycosis. Neurologic exam is nonfocal. Laboratory tests: hemoglobin 10.2 g/dL, platelets 310,000/µL, WBC 12,600/µL; creatinine 4.5 mg/dL (baseline 1.0), BUN 72 mg/dL; eGFR (CKD‑EPI 2021) 15.0 mL/min/1.73 m²; bicarbonate 18 mEq/L; albumin 3.1 g/dL; AST/ALT 24/23 U/L. Urinalysis shows 3 blood, 2 protein, dysmorphic RBCs and several RBC casts. Urine culture is negative. Autoimmune serology: c‑ANCA 1:320 with strongly positive PR3‑ANCA; ANA negative; ENA panel negative; anti‑GBM negative; complements normal. Inflammatory markers are elevated (ESR, CRP). Chest radiograph shows diffuse reticulonodular opacities; bedside lung ultrasound reveals scattered B‑lines without pleural effusions. Arterial blood gas on room air shows pH 7.38, PaCO2 34 mm Hg, PaO2 82 mm Hg, without hypoxemia. Kidney ultrasound shows normal‑sized echogenic kidneys without hydronephrosis. Additional recent results available from routine care include LDL‑C 88 mg/dL and TSH 1.3 mIU/L. Pulmonary function testing from last year demonstrated mildly reduced DLCO. ECG shows normal sinus rhythm. Nephrology and rheumatology note organ‑threatening PR3‑ANCA–associated pauci‑immune glomerulonephritis with pulmonary involvement, very high relapse risk, severe hypertension, and no dialysis requirement or life‑threatening diffuse alveolar hemorrhage. They aim to minimize glucocorticoid exposure while using an evidence‑based induction strategy to maximize renal recovery. Which treatment approach is most appropriate now? **Start rituximab 1,000 mg IV on days 1 and 15 plus avacopan 30 mg orally twice daily, use only short peri‑infusional methylprednisolone 250–500 mg IV daily for 1–3 days without a prolonged oral prednisone course, admit for monitoring with Pneumocystis prophylaxis and aggressive blood‑pressure control; do not add plasma exchange absent dialysis or hypoxemic DAH.** **Give rituximab 1,000 mg IV on days 1 and 15 with a traditional oral prednisone 1 mg/kg/day taper over ~6 months, omit avacopan, and perform routine plasma exchange (7 sessions over 14 days) despite preserved oxygenation and no dialysis.** **Initiate intravenous cyclophosphamide 15 mg/kg every 2–3 weeks for 6 pulses plus avacopan 30 mg twice daily, continue high‑dose oral prednisone 1 mg/kg/day for 6 months before tapering, and plan elective outpatient plasma exchange regardless of respiratory status.** **Administer rituximab 375 mg/m² IV weekly for 4 weeks together with avacopan 30 mg twice daily but also add immediate plasma exchange and maintain prednisone 0.5 mg/kg/day for 3 months even though there is no hypoxemia or dialysis need.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #TherapeuticImmunosuppression #Medical #EndlessMedicalAcademy #EndlessMedicalcom #NephrologyKidneyDiseaseDiagnosisandManagement #EndlessMedical #GlomerulonephritisCausesDiagnosisandManagement #MedicalEducation #PauciImmuneGlomerulonephritisGN #MCQ #MultipleChoiceQuestions Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis - KDIGO - (2024) - by KDIGO ANCA Vasculiti... Confidence: 100% Educational value: Concise framework for induction/maintenance, steroid-sparing strategies, and relapse risk (e.g., PR3-ANCA). pubmed.ncbi.nlm.nih.gov/3838… 2. 2025 British Society for Rheumatology management recommendations for ANCA‑associated vasculitis (Executive summary) - British Society for Rheumatology - (2025) - by British Society for ... Confidence: 100% Educational value: Clarifies treatment pathways, steroid tapering, and PR3‑ANCA relapse‑risk considerations. academic.oup.com/rheumatolog… 3. Avacopan for the Treatment of ANCA‑Associated Vasculitis - New England Journal of Medicine - (2021) - by Jayne DRW, Merkel PA... Confidence: 100% Educational value: Provides high‑quality evidence for adding C5aR inhibition to standard induction to minimize steroid toxicity. pubmed.ncbi.nlm.nih.gov/3359… 4. Vasculitis — MedlinePlus Health Topic - MedlinePlus - (2024) - by U.S. National Librar... Confidence: 100% Educational value: Introduces symptoms, diagnostics, and treatment terminology for learners. medlineplus.gov/vasculitis.h… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

So you think you're smart? Prove it! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) A 62-year-old woman presents with 3 weeks of dark “cola-colored” urine, decreasing urine output, fatigue, and ankle swelling. Four months ago her serum creatinine was 0.8 mg/dL at a routine visit. Medical history includes long-standing hypertension treated with amlodipine 10 mg daily and over-the-counter fish oil; she takes no NSAIDs. She denies fevers, cough, hemoptysis, oral ulcers, or chronic sinus symptoms and reports no recent infections or new drugs. On arrival, temperature is 37.2 °C, pulse 92/min, respirations 18/min, and blood pressure 176/96 mm Hg (usual clinic readings ~128/78 mm Hg). Examination shows mild periorbital puffiness and bilateral pitting edema to the mid-shins; there is no rash, synovitis, or nasal crusting. She has mild paraspinal tenderness from gardening. Laboratory studies Serum creatinine 2.1 mg/dL; blood urea nitrogen 38 mg/dL; potassium 4.7 mEq/L; bicarbonate 19 mEq/L Hemoglobin 11.4 g/dL; platelets 312 × 10^9/L; leukocytes 8.6 × 10^9/L (normal differential) C3 106 mg/dL (reference 90–180); C4 26 mg/dL (reference 10–40) Urinalysis: 3 blood, 2 protein; many dysmorphic erythrocytes; numerous erythrocyte casts; spot protein-to-creatinine ratio 2.2 g/g creatinine ANA negative; anti–double-stranded DNA negative; anti–glomerular basement membrane antibody negative Hepatitis B surface antigen negative; hepatitis C antibody negative; HIV antigen/antibody negative Proteinase-3 ANCA negative; myeloperoxidase ANCA positive at 58 U/mL (reference <20 U/mL) Thyroid-stimulating hormone 1.7 mIU/L Imaging Renal ultrasonography: normal-sized kidneys without obstruction. Chest radiograph: clear lungs without infiltrates. Ultrasound-guided percutaneous kidney biopsy (22 glomeruli) shows necrotizing crescentic glomerulonephritis in 15 glomeruli with segmental fibrinoid necrosis; immunofluorescence reveals no significant immunoglobulin or complement deposition (pauci-immune pattern). She is not on dialysis and has no pulmonary hemorrhage. The nephrology service is preparing to initiate remission induction with pulse glucocorticoids and either rituximab or cyclophosphamide. Which of the following is the most appropriate next diagnostic step before initiating immunosuppressive therapy? **Perform bronchoscopy with serial bronchoalveolar lavage aliquots today in the ICU to evaluate for occult diffuse alveolar hemorrhage despite a clear chest radiograph and no respiratory symptoms.** **Collect a 24-hour urine protein measurement before starting treatment to better quantify proteinuria rather than using the spot urine protein-to-creatinine ratio that is already available.** **Order repeat ANCA titers now to establish a numeric baseline for disease-activity monitoring and use titer changes to guide early decisions about induction regimen selection.** **Obtain baseline hepatitis B serologies today in the inpatient setting—HBsAg, total anti-HBc, and anti-HBs—by venous blood draw prior to rituximab or cyclophosphamide, with plans for antiviral prophylaxis if indicated.** 🎬 Watch the video explanation: youtube.com/watch?v=2lBeVQMx… The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #Medical #MultipleChoiceQuestions #MCQ #EndlessMedicalAcademy #EndlessMedicalcom #GlomerulonephritisCausesDiagnosisandManagement #NephrologyKidneyDiseaseDiagnosisandManagement #PauciImmuneGlomerulonephritisGN #MedicalEducation #EndlessMedical Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis - (2024) - by KDIGO Work Group Confidence: 100% Educational value: Provides evidence-based algorithms and graded recommendations that help learners understand when to choose specific induction/maintenance regimens, how to taper steroids, monitor response, and mitigate treatment toxicity in AAV. kdigo.org/guidelines/antineu… 2. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance - (2018) - by Terrault NA, Lok ASF... Confidence: 100% Educational value: Helps learners integrate HBV screening, risk stratification, prophylaxis, and monitoring into treatment plans involving immunosuppression, reinforcing patient safety principles alongside disease-directed therapy. pmc.ncbi.nlm.nih.gov/article… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Get better every day and solve this! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Transplant-Related Glomerulonephritis (GN) A 59-year-old woman with a history of biopsy-proven glomerulopathy that progressed to end-stage kidney disease received a deceased-donor kidney transplant 14 months ago. Her medical history includes paroxysmal atrial fibrillation (apixaban 5 mg twice daily), primary open-angle glaucoma (latanoprost nightly), major depressive disorder (sertraline 100 mg daily), and mild intermittent asthma (albuterol as needed). Current immunosuppression is tacrolimus 4 mg twice daily (trough 5.8 ng/mL), mycophenolate mofetil 1 g twice daily, and prednisone 5 mg daily. She smokes 10 cigarettes daily and uses marijuana most evenings. At routine follow-up she reports 2 weeks of new frothy urine without flank pain, fever, rash, or arthralgia. Vital signs: temperature 36.1 °C, pulse 72/min, blood pressure 129/83 mm Hg, respiratory rate 9/min, oxygen saturation 98% on room air. Physical examination shows periorbital puffiness and mild bilateral ankle oedema; the remainder is unremarkable. Laboratory studies: • Serum creatinine 2.1 mg/dL (baseline 1.1 mg/dL three months earlier) • Blood urea nitrogen 36 mg/dL • Serum albumin 2.7 g/dL • Total cholesterol 265 mg/dL • Spot urine protein-to-creatinine ratio 6.8 g/g • Urinalysis: 3 protein, 10–15 dysmorphic red blood cells/high-power field, no leukocytes • Complement: C3 42 mg/dL (low), C4 30 mg/dL (normal) • BK-virus plasma PCR negative • Donor-specific HLA antibody screen negative • ANA, ANCA, and anti-dsDNA negative (unchanged from baseline) Renal allograft ultrasound with Doppler shows normal size, echogenicity, and flow. Allograft biopsy: • Light microscopy: mesangial and intramembranous electron-dense deposits with double-contoured glomerular basement membranes • Immunofluorescence: bright C3 (3 ) along glomerular capillary walls; IgG, IgA, IgM, C1q, κ, and λ absent • Electron microscopy: ribbon-like intramembranous deposits. What is the most likely primary glomerular disease causing her current presentation? **Dense deposit disease (C3 glomerulopathy)** **Membranous nephropathy associated with hepatitis B** **Primary focal segmental glomerulosclerosis** **IgA nephropathy** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #MultipleChoiceQuestions #LabMedicine #Medicine #ClinicalCases #NephrologyKidneyDiseaseDiagnosisandManagement #MedEd #MedStudents #CKD #WomenInMedicine #CME #Healthcare #HighYield #InternLife @kidney_boy @andrew_malone @hswapnil @TransplantJC @ERA_EDTA @NephOnTour @JAMA_current @NEJM @nkf @TheLancet Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

This question is for you! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management A 76-year-old woman with psoriasis (treated with topical corticosteroids), peripheral neuropathy, osteoporosis with a prior L1 vertebral compression fracture, type 2 diabetes mellitus (last HbA1c 8.2%), and hyperlipidemia presents with three weeks of hematuria, subnephrotic proteinuria, and rising creatinine, accompanied by nasal crusting and cough. She quit smoking 15 years ago and occasionally uses marijuana. She owns cats. She reports a tetracycline rash in the past and a remote appendectomy. Current medications include metformin 1,000 mg twice daily, gabapentin 300 mg at bedtime, alendronate 70 mg once weekly, calcium carbonate with vitamin D daily, atorvastatin 20 mg nightly, and topical triamcinolone. Vital signs: pulse 76 beats/min, blood pressure 118/68 mm Hg, respiratory rate 14 breaths/min, temperature 36.8 °C, oxygen saturation 96% on room air. Exam shows mild ankle edema, scattered palpable purpura over the shins, and bilateral basilar crackles. Laboratory results: hemoglobin 10.2 g/dL, leukocytes 11,800/µL, platelets 280,000/µL, creatinine 2.3 mg/dL, BUN 42 mg/dL, C-reactive protein 28 mg/L, AST 24 U/L, ALT 22 U/L. Urinalysis shows dysmorphic red blood cells and red blood cell casts; spot urine protein/creatinine ratio 0.9 g/g. PR3-ANCA is positive; complements are normal; hepatitis B surface antigen and hepatitis C antibody are negative. Respiratory viral panel is negative. Renal ultrasound shows no obstruction. Kidney biopsy is planned, and rituximab-based induction will be started for new-onset granulomatosis with polyangiitis with renal involvement. Given age, diabetes, and osteoporosis, the team considers adding avacopan to reduce glucocorticoid exposure during induction. Which statement best describes the mechanism and usual dosing schedule of avacopan in ANCA-associated vasculitis? **Tocilizumab, an anti–IL-6 receptor monoclonal antibody; 162 mg subcutaneously weekly for 52 weeks as monotherapy replacing rituximab during induction, managed in outpatient specialty care.** **Eculizumab, a terminal complement C5 inhibitor; 900 mg intravenously weekly for four weeks then 1,200 mg every two weeks as monotherapy to replace glucocorticoids, administered in an infusion center.** **Belimumab, a BAFF-ligand inhibitor; 10 mg/kg intravenously at weeks 0, 2, and 4, then every four weeks, used as a steroid substitute during induction in an infusion suite.** **Avacopan, an oral C5a receptor 1 antagonist that blocks C5a–C5aR1 neutrophil signaling; 30 mg by mouth twice daily with food, started with or shortly after rituximab and continued up to 52 weeks in specialty care.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #Medical #EndlessMedicalAcademy #GlomerulonephritisCausesDiagnosisandManagement #EndlessMedicalcom #EndlessMedical #MedicalEducation #PauciImmuneGlomerulonephritisGN #NephrologyKidneyDiseaseDiagnosisandManagement #AcuteKidneyInjuryManagement #MultipleChoiceQuestions #MCQ Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. FDA approves add-on drug for adults with ANCA-associated vasculitis (Tavneos/avacopan) with recommended dosing. - U.S. Food and Drug Administration - (2021) - by U.S. Food and Drug A... Confidence: 100% Educational value: Clarifies labeled dosing (e.g., oral twice-daily with food) and pharmacologic target for exam and clinical use. fda.gov/drugs/news-events-hu… 2. Avacopan for the Treatment of ANCA-Associated Vasculitis - New England Journal of Medicine - (2021) - by Jayne DRW; Merkel PA... Confidence: 100% Educational value: Provides trial evidence, dosing context (30 mg twice daily), outcomes, and safety profile to understand clinical application. pubmed.ncbi.nlm.nih.gov/3359… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Get better every day and solve this! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) A 45-year-old man with type 1 diabetes mellitus diagnosed at age 18, a 25-pack-year past smoking history (quit 5 years ago), and a recent 2-month history of intermittent epistaxis and chronic rhinosinusitis is seen in the nephrology clinic for follow-up of an unexpected rise in serum creatinine noted 6 weeks ago. He reports cola-colored urine for the past week but otherwise feels well. He denies rash, arthralgias, oral ulcers, photosensitivity, or recent upper respiratory infections. Family history is negative for kidney disease, autoimmune disorders, or systemic vasculitis. Past medical history includes nonproliferative diabetic retinopathy confirmed on a dilated eye examination 1 year ago and distal symmetric peripheral neuropathy diagnosed 3 years ago. He has no known cardiovascular disease and no history of venous thromboembolism, malignancy, or chronic liver disease. He drinks 1–2 beers on weekends and denies illicit drug use. He works as an accountant and has not had recent travel or occupational solvent exposure. Current medications are insulin glargine administered once nightly, gabapentin 300 mg three times daily for neuropathic pain, lisinopril 10 mg once daily for blood pressure and renal protection, atorvastatin 40 mg nightly for dyslipidemia, and low-dose aspirin 81 mg daily started 2 years ago for primary cardiovascular prevention. He takes no over-the-counter nonsteroidal anti-inflammatory drugs or herbal supplements. He has no known drug allergies. On examination, vital signs are temperature 37.0 °C, heart rate 92 beats/min, respiratory rate 14 breaths/min, blood pressure 128/78 mm Hg, and oxygen saturation 98 % on room air. He appears comfortable and in no acute distress. HEENT examination shows mild nasal mucosal edema without septal perforation or oral ulceration; there is no conjunctival injection. Cardiovascular examination reveals a regular rhythm without murmurs or rubs. Pulmonary auscultation is clear bilaterally. Abdominal examination is benign without organomegaly. There is no peripheral edema, livedo reticularis, or palpable purpura. Laboratory studies show hemoglobin 10.2 g/dL, leukocytes 8 600/µL, platelets 290 000/µL, erythrocyte sedimentation rate 68 mm/h, C-reactive protein 32 mg/L, serum creatinine 2.1 mg/dL (baseline 0.9 mg/dL 6 weeks earlier), blood urea nitrogen 36 mg/dL, and potassium 4.8 mmol/L. An outpatient hemoglobin A1c measured 3 months earlier was 7.6 %, and a fasting lipid panel at that time showed LDL cholesterol 86 mg/dL. Liver enzymes are normal. Urinalysis reveals 3 blood, 1 protein, numerous dysmorphic erythrocytes, and occasional red blood cell casts on microscopy; there is no pyuria or bacteriuria. Spot urine protein-to-creatinine ratio is 0.6 g/g. Complement levels (C3, C4) are normal, and anti–glomerular basement membrane antibodies are negative. Antinuclear antibody testing is negative. PR3-ANCA (c-ANCA) is strongly positive by ELISA, whereas MPO-ANCA is negative. A chest radiograph shows no parenchymal infiltrates or nodules. Renal ultrasonography demonstrates normal-sized kidneys without obstruction. Percutaneous kidney biopsy shows more than 50 % cellular crescents with fibrinoid necrosis on light microscopy and minimal immunoglobulin or complement deposition on immunofluorescence, reported as pauci-immune crescentic glomerulonephritis. After extensive counseling by nephrology and rheumatology regarding high-dose glucocorticoids combined with cyclophosphamide or rituximab, the patient declines all forms of immunosuppressive therapy and opts for close observation only. Which of the following best describes the expected natural history of his renal disease over the next 6–12 months if no specific treatment is initiated? **Renal function typically declines slowly over 10–15 years, and dialysis is rarely required** **Extra-renal vasculitic flares are common, but renal function remains stable in most untreated patients** **Most patients progress rapidly to end-stage kidney disease or die within 1 year** **Spontaneous remission with return to baseline renal function occurs in the majority of cases** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #MedicalEducation #GlomerulonephritisCausesDiagnosisandManagement #PauciImmuneGlomerulonephritisGN #Medical #EndlessMedicalAcademy #NephrologyKidneyDiseaseDiagnosisandManagement #MCQ #EndlessMedicalcom #EndlessMedical #MultipleChoiceQuestions Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. Further reading: 1. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis - (2024) - by Kidney Disease: Impr... Confidence: 100% Educational value: Provides structured, graded recommendations and rationale on evaluation, choice of immunosuppressive regimens, glucocorticoid use, and monitoring in ANCA-associated vasculitis, making it an essential resource for learners to understand contemporary, guideline-based management. kdigo.org/guidelines/antineu… 2. Rapidly Progressive Glomerulonephritis - by Bansal AD, Confidence: 100% Educational value: Offers a learner-friendly, clinically oriented overview that integrates pathophysiology, clinical presentation, workup, and treatment of rapidly progressive glomerulonephritis, helping trainees connect guideline recommendations with the broader disease framework. ncbi.nlm.nih.gov/sites/books… Links to sources are provided for optional further reading only. *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Get better every day and solve this! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management A 27‑year‑old woman presents with 10 days of fatigue, pleuritic chest tightness, red‑tinged sputum, ankle swelling, and dark urine. She works as a respiratory therapist. She quit smoking one month ago after a 10 pack‑year history and denies alcohol use. Six months ago her baseline serum creatinine was 0.9 mg/dL. Two months ago hydralazine 50 mg orally three times daily was added for difficult blood pressure. Current medications include hydralazine 50 mg three times daily, amlodipine 10 mg daily, and a daily multivitamin. On arrival: temperature 36.5 °C, HR 118/min, RR 18/min, BP 152/88 mm Hg, SpO2 89% on room air improving to 94% on 2 L/min by nasal cannula. She is winded but speaks full sentences. Lungs have scattered crackles without wheeze; there is no rash or synovitis; trace bilateral pitting edema is present. Labs: hemoglobin 9.9 g/dL, leukocytes 11,600/µL, platelets 402,000/µL, ESR 78 mm/h, CRP 96 mg/L. Basic metabolic panel: BUN 38 mg/dL, creatinine 2.6 mg/dL (CKD‑EPI 2021 eGFR ≈ 25.2 mL/min/1.73 m²), bicarbonate 20 mEq/L, potassium 4.9 mEq/L. Urinalysis shows 3 blood with many dysmorphic red cells and red cell casts; urine protein/creatinine ratio 0.8 g/g. MPO‑ANCA is strongly positive; PR3‑ANCA is borderline. Complements are normal. HIV, HBV, and HCV screens are negative. Chest CT demonstrates diffuse ground‑glass opacities compatible with alveolar hemorrhage; ECG shows sinus tachycardia. Kidney ultrasound reveals normal‑sized kidneys without obstruction. Platelets and INR are normal. Bronchoscopy and percutaneous kidney biopsy are being arranged to document diffuse alveolar hemorrhage and active glomerulonephritis. The team plans pulse steroids and rituximab for induction if infection is excluded. The admitting resident asks about antihypertensive management right now in the setting of suspected drug‑associated ANCA vasculitis with lung–kidney involvement. Which of the following actions is contraindicated now? **Switch hydralazine to clonidine 0.1 mg orally twice daily for short‑term blood‑pressure control and coordinate urgent induction therapy once infection and pulmonary hemorrhage have been properly documented.** **Stop hydralazine immediately and begin methylprednisolone 500–1000 mg IV daily for 3 days followed by prednisone 1 mg/kg/day; give rituximab 1 g IV on days 1 and 15; start Pneumocystis prophylaxis.** **Continue hydralazine 50 mg orally three times daily for blood‑pressure control while initiating immunosuppression for suspected ANCA‑associated vasculitis.** **Replace hydralazine with labetalol 200 mg orally twice daily for blood‑pressure control and proceed with induction immunosuppression after bronchoscopy confirms alveolar hemorrhage and cultures remain negative.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #MedicalEducation #AcuteKidneyInjuryManagement #EndlessMedical #GlomerulonephritisCausesDiagnosisandManagement #EndlessMedicalcom #EndlessMedicalAcademy #Medical #MultipleChoiceQuestions #PauciImmuneGlomerulonephritisGN #NephrologyKidneyDiseaseDiagnosisandManagement #MCQ Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. References: 1. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA‑Associated Vasculitis (2024) (pubmed.ncbi.nlm.nih.gov/3838…) 2. Granulomatosis with Polyangiitis (Health Topic) (2025) (medlineplus.gov/granulomatos…) 3. Sequential carbonyl derivatives and hydrazone adduct formation on myeloperoxidase contribute to development of ANCA vasculitis (2025) (jci.org/articles/view/178813) *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Today we will learn about... Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management A 4-year-old boy is brought to the pediatric emergency department for 2 days of dark urine, pallor, and rapid breathing. He was treated for giardiasis 6 months ago. At age 3 he was evaluated for paroxysmal episodes of sweating and pallor; outpatient imaging suggested an adrenal lesion, but serial evaluations since then have not confirmed catecholamine excess, and he has needed no therapy. He has no known congenital syndromes based on next-generation sequencing performed last year (MEN2, VHL, and NF1 panels negative). He lives with his parents, attends preschool, and has up-to-date immunizations. He has been in recovery from accidental opioid ingestion in the household 3 years ago (no continued exposure). Allergies include nickel (contact rash), iodine contrast (flushing), wheat (bloating), codeine (nausea), fish (nausea), and aspirin (angioedema). There is no family history of kidney failure or hearing loss. On arrival he is pale and tachypneic, speaking in short phrases. Vital signs: pulse 146/min, respiratory rate 81/min, temperature 37.9°C, blood pressure 107/62 mmHg, oxygen saturation 92% on room air improving to 97% on 4 L/min nasal cannula. Physical exam shows dried nasal crusts, mild frontal sinus tenderness, clear oropharynx, bilateral coarse inspiratory crackles at lung bases, no wheeze, no hepatosplenomegaly, and a soft systolic flow murmur. He has mild ankle edema without arthritis and a subtle right foot-drop compared with the left; no purpura is present. Initial pediatric ED tests: arterial blood gas on room air shows pH 7.33, PaCO2 30 mmHg, PaO2 58 mmHg; complete blood count shows hemoglobin 7.4 g/dL, leukocytes 12,200/µL, platelets 410,000/µL; comprehensive metabolic panel shows creatinine 1.2 mg/dL, BUN 36 mg/dL, sodium 140 mEq/L, chloride 102 mEq/L, bicarbonate 20 mEq/L, AST/ALT normal; urinalysis shows 3 blood, 2 protein, dysmorphic red cells, and numerous red cell casts. PCR testing of nasopharyngeal swab is negative for influenza A/B, RSV, and SARS-CoV-2; respiratory bacterial PCR panel negative. Portable chest radiograph shows new bilateral patchy perihilar and basilar opacities without cardiomegaly. Bronchoscopy with sequential bronchoalveolar lavage (performed for hypoxemia and diffuse opacities once oxygenation stabilized) reveals increasingly bloody aliquots and hemosiderin-laden macrophages consistent with diffuse alveolar hemorrhage; no bacterial growth on bronchoalveolar cultures at 48 hours. Inpatient evaluation over the next several hours demonstrates normal complement C3/C4, negative anti-GBM antibodies, and ANCA by immunofluorescence with a cytoplasmic pattern; antigen-specific ELISA shows PR3 strongly positive and MPO negative. An urgent percutaneous native-kidney biopsy (after platelets and blood pressure were stabilized) shows crescents in >50% of glomeruli with necrotizing lesions and pauci-immune pattern on immunofluorescence and electron microscopy. A comprehensive metabolic panel checked for hypoparathyroidism screening shows calcium 7.8 mg/dL and albumin 2.4 g/dL; repeat calculation corrects total calcium to approximately normal. Next-generation sequencing from last year is reviewed and remains negative for inherited complement pathway disorders. Arterial blood gas repeated on 4 L/min oxygen shows PaO2 92 mmHg with improving work of breathing. Medications in the ED included a single dose of IV methylprednisolone 30 mg/kg (not to exceed 1 g) and IV proton pump inhibitor; he is not on other immunosuppressants. Pediatric infectious diseases advises early Pneumocystis prophylaxis if continued high-dose steroids and induction immunotherapy are used. Pediatric nephrology is consulted to integrate the multisystem findings (upper airway inflammation, neuropathic foot-drop, diffuse alveolar hemorrhage, and pauci-immune crescentic glomerulonephritis) and distinguish among potential causes of pulmonary–renal syndrome in a child. Which diagnosis best integrates the history, examination, and the full data set to guide initial management in this child? **Granulomatosis with polyangiitis (PR3‑ANCA–associated pauci‑immune small‑vessel vasculitis) presenting with pulmonary–renal syndrome and mononeuritis multiplex.** **Microscopic polyangiitis (MPO‑ANCA vasculitis) with pulmonary–renal syndrome despite PR3‑positive and MPO‑negative serology.** **Infection‑related glomerulonephritis with concurrent community‑acquired pneumonia producing hematuria and diffuse alveolar hemorrhage.** **Anti–glomerular basement membrane antibody disease (Goodpasture disease) causing pulmonary–renal syndrome with immune‑complex deposition on kidney biopsy.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #Medical #PauciImmuneGlomerulonephritisGN #EndlessMedicalAcademy #EndlessMedical #MedicalEducation #GlomerulonephritisCausesDiagnosisandManagement #MultipleChoiceQuestions #AcuteKidneyInjuryManagement #NephrologyKidneyDiseaseDiagnosisandManagement #EndlessMedicalcom #MCQ Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. References: 1. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (2024) (pubmed.ncbi.nlm.nih.gov/3838…) 2. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis (2021) (pubmed.ncbi.nlm.nih.gov/3423…) 3. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (2020) (pubmed.ncbi.nlm.nih.gov/3205…) 4. Glomerular Disease (2022) (niddk.nih.gov/health-informa…) *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

So you think you're smart? Prove it! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management A 76-year-old woman with psoriasis (treated with topical corticosteroids), peripheral neuropathy, osteoporosis with a prior L1 vertebral compression fracture, type 2 diabetes mellitus (last HbA1c 8.2%), and hyperlipidemia presents with three weeks of hematuria, subnephrotic proteinuria, and rising creatinine, accompanied by nasal crusting and cough. She quit smoking 15 years ago and occasionally uses marijuana. She owns cats. She reports a tetracycline rash in the past and a remote appendectomy. Current medications include metformin 1,000 mg twice daily, gabapentin 300 mg at bedtime, alendronate 70 mg once weekly, calcium carbonate with vitamin D daily, atorvastatin 20 mg nightly, and topical triamcinolone. Vital signs: pulse 76 beats/min, blood pressure 118/68 mm Hg, respiratory rate 14 breaths/min, temperature 36.8 °C, oxygen saturation 96% on room air. Exam shows mild ankle edema, scattered palpable purpura over the shins, and bilateral basilar crackles. Laboratory results: hemoglobin 10.2 g/dL, leukocytes 11,800/µL, platelets 280,000/µL, creatinine 2.3 mg/dL, BUN 42 mg/dL, C-reactive protein 28 mg/L, AST 24 U/L, ALT 22 U/L. Urinalysis shows dysmorphic red blood cells and red blood cell casts; spot urine protein/creatinine ratio 0.9 g/g. PR3-ANCA is positive; complements are normal; hepatitis B surface antigen and hepatitis C antibody are negative. Respiratory viral panel is negative. Renal ultrasound shows no obstruction. Kidney biopsy is planned, and rituximab-based induction will be started for new-onset granulomatosis with polyangiitis with renal involvement. Given age, diabetes, and osteoporosis, the team considers adding avacopan to reduce glucocorticoid exposure during induction. Which statement best describes the mechanism and usual dosing schedule of avacopan in ANCA-associated vasculitis? **Belimumab, a BAFF-ligand inhibitor; 10 mg/kg intravenously at weeks 0, 2, and 4, then every four weeks, used as a steroid substitute during induction in an infusion suite.** **Tocilizumab, an anti–IL-6 receptor monoclonal antibody; 162 mg subcutaneously weekly for 52 weeks as monotherapy replacing rituximab during induction, managed in outpatient specialty care.** **Eculizumab, a terminal complement C5 inhibitor; 900 mg intravenously weekly for four weeks then 1,200 mg every two weeks as monotherapy to replace glucocorticoids, administered in an infusion center.** **Avacopan, an oral C5a receptor 1 antagonist that blocks C5a–C5aR1 neutrophil signaling; 30 mg by mouth twice daily with food, started with or shortly after rituximab and continued up to 52 weeks in specialty care.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #EndlessMedicalAcademy #NephrologyKidneyDiseaseDiagnosisandManagement #AcuteKidneyInjuryManagement #Medical #MedicalEducation #EndlessMedicalcom #EndlessMedical #MultipleChoiceQuestions #GlomerulonephritisCausesDiagnosisandManagement #MCQ #PauciImmuneGlomerulonephritisGN Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. References: 1. Avacopan for the Treatment of ANCA-Associated Vasculitis (2021) (pubmed.ncbi.nlm.nih.gov/3359…) 2. FDA approves add-on drug for adults with ANCA-associated vasculitis (Tavneos/avacopan) with recommended dosing. (2021) (fda.gov/drugs/news-events-hu…) *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Get better every day and solve this! Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management A 23-year-old woman at 10 weeks’ gestation is transferred for evaluation of suspected ANCA-associated pauci-immune glomerulonephritis after 5 days of cola-colored urine and shortness of breath. She reports mild sinus congestion, no fever, and new ankle swelling. Past history includes congenital hydrocephalus with ventriculoperitoneal shunt, anxiety, and Brugada pattern type 2 on prior ECG without syncope. She was treated for non–muscle-invasive bladder cancer at age 20 with complete remission; surveillance cystoscopy before conception was normal. She quit smoking 1 year ago after 15 pack-years and drinks no alcohol. No drug allergies. On exam, she is alert and in no distress. Vitals: temperature 37.3°C, pulse 102/min, blood pressure 128/78 mm Hg, respiratory rate 20/min, oxygen saturation 96% on room air. She has pale palpebral conjunctivae, clear lungs with shallow respirations, regular heart rhythm without murmur, gravid nontender abdomen, and trace bilateral ankle edema. There is no rash or joint swelling. Neurologic exam is nonfocal. Laboratory testing shows creatinine 2.0 mg/dL (baseline unknown), BUN 36 mg/dL, potassium 5.2 mEq/L, bicarbonate 20 mEq/L, hemoglobin 10.0 g/dL, platelets 310 ×10^9/L. Urinalysis reveals odd-shaped red blood cells and red blood cell casts; urine protein/creatinine ratio 1.2 g/g. Complements are normal; anti–GBM antibody is negative. ANCA testing is positive with MPO pattern by ELISA. ECG confirms Brugada type 2 pattern without acute changes. Obstetric ultrasound confirms a live intrauterine pregnancy consistent with 10 weeks. A recent dental exam was normal. She is taking a prenatal vitamin and ondansetron as needed for nausea. In a first-trimester pregnant patient with organ-threatening kidney disease consistent with MPO-ANCA–associated pauci-immune crescentic glomerulonephritis, which single option below is contraindicated in pregnancy? **Oral azathioprine 1.5–2.0 mg/kg/day for maintenance in mid-to-late pregnancy while tapering glucocorticoids to the lowest effective dose in the outpatient clinic.** **Intravenous rituximab 1 g on days 1 and 15 with high-dose glucocorticoids, in an inpatient infusion unit, with neonatal B-cell monitoring if exposure extends into late gestation.** **Intravenous cyclophosphamide 500–750 mg every 3–4 weeks, restricted to the second or third trimester for life- or organ-threatening disease, with MESNA and coordinated maternal–fetal monitoring in the inpatient infusion unit.** **Oral mycophenolate mofetil 1,000 mg twice daily for induction or maintenance during any trimester, in an outpatient setting.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #PauciImmuneGlomerulonephritisGN #EndlessMedical #MultipleChoiceQuestions #MCQ #NephrologyKidneyDiseaseDiagnosisandManagement #MedicalEducation #EndlessMedicalcom #EndlessMedicalAcademy #AcuteKidneyInjuryManagement #GlomerulonephritisCausesDiagnosisandManagement #Medical Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. References: 1. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids (2023) (academic.oup.com/rheumatolog…) 2. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases (2020) (pubmed.ncbi.nlm.nih.gov/3209…) *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…

Today we will learn about... Category: Nephrology: Kidney Disease Diagnosis and Management > Glomerulonephritis: Causes, Diagnosis, and Management > Pauci-Immune Glomerulonephritis (GN) > Acute Kidney Injury Management An 82-year-old woman comes to her primary care clinic for a routine visit and medication refill. For two weeks she has noticed dark, cola-colored urine, new ankle swelling, and getting tired after walking short distances. She denies fever, burning with urination, or back pain. Past history includes well-controlled high blood pressure and a remote pelvic infection. She received a flu shot three weeks ago and owns two cats. She quit alcohol five years ago and smokes one pack per day. Current medicines are lisinopril 10 mg once daily, furosemide 20 mg once daily, aspirin 81 mg once daily, and loratadine 10 mg as needed. Vital signs in clinic after five minutes seated: pulse 102 beats/min and blood pressure 130/76 mm Hg. She is alert, tired-appearing. Chest exam has soft crackles at the bases. There is 1 pitting edema at both ankles. Oral exam notes several dental caries. Abdomen is soft and nontender. Same-day tests: urinalysis shows 3 blood and 2 protein with many red blood cells; a spot urine protein/creatinine ratio is 1.4 g/g. Serum creatinine is 3.0 mg/dL; six months ago it was 0.9 mg/dL. Blood urea nitrogen is 48 mg/dL. A kidney ultrasound shows normal-sized kidneys without blockage. A chest x-ray shows mild atelectasis at the bases. The clinic can draw blood for antibody tests today, but results will return later. The clinic cannot give IV medicines or perform a kidney biopsy. The clinician must choose the best next step today that helps her kidneys and uses care wisely. What is the single best next step today? **Treat as a urinary tract infection with cephalexin 500 mg by mouth every 6 hours for 7 days and arrange routine clinic follow-up.** **Call nephrology for an urgent clinic visit tomorrow, start prednisone 30 mg by mouth daily at home, and schedule a kidney biopsy next week.** **Increase furosemide to 40 mg by mouth daily at home, recheck urine and blood tests in four weeks, and delay any specialist referral.** **Arrange same-day transfer to the emergency department for admission by nephrology, urgent kidney biopsy, and hospital-started prednisone about 30 mg by mouth daily under supervision.** The answer and explanation will be shared as a reply to this post later on. Visit endlessmedical.academy/auth?… to discover the correct answer and detailed explanation right now. #Medical #EndlessMedicalAcademy #PauciImmuneGlomerulonephritisGN #GlomerulonephritisCausesDiagnosisandManagement #AcuteKidneyInjuryManagement #NephrologyKidneyDiseaseDiagnosisandManagement #MedicalEducation #EndlessMedical #EndlessMedicalcom #MultipleChoiceQuestions #MCQ Dig deeper on this topic at endlessmedical.ai, where multiple AI models debate, cross-check references, and verify calculations to give you the most updated and accurate medical information with minimal hallucinations and errors. References: 1. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (2024) (pubmed.ncbi.nlm.nih.gov/3838…) 2. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (2020) (pubmed.ncbi.nlm.nih.gov/3205…) *Generated by AI. May contain errors. Use at own risk. Full disclaimer: endlessmedical.academy/auth?…